China Approves World's First Commercial Brain Implant as Sector Heats Up
China became the first nation on March 13, granting commercial regulatory clearance to Neuracle Technology of Shanghai for its world-first implantable EEG-based brain-computer interface designed to restore hand movement in patients with spinal cord injuries. This approval marks a significant milestone as China positions itself ahead of competitors like Elon Musk's Neuralink and aims to bring practical public use of BCI technology within three to five years, according to industry analysts monitoring the sector's rapid evolution from experimental research toward commercial deployment.
Key Points
-
1China became the first country in history to grant commercial regulatory clearance (NMPA) for an invasive Brain-Computer Interface medical device.
-
2The approved system, developed by Shanghai-based Neuracle Technology and featuring implanted EEG electrodes, aims to restore hand movement for patients with spinal cord injuries.
-
3This approval marks a significant milestone as the technology moves from research toward practical public application within three to five years in China's market context.
Developments
China's National Medical Products Administration has approved Neuracle Technology for a world-first commercial brain-computer interface designed to restore hand movement in partially paralyzed adults. This regulatory milestone follows broader government support from the Chinese sector as it seeks global competition with companies like Neuralink, while other domestic BCI startups recently secured significant funding rounds and investment backing.